
FintechEnterprise SoftwareLogistics & Supply ChainHealthcareFood & AgricultureMobility & Transportation
Mubadala Investment Company's venture capital arm, Mubadala Capital Ventures, focuses on investing in technology and healthcare companies globally. Their strategy involves backing exceptional founders in areas like AI and next-generation compute architecture, with investments ranging from Series A+ in the U.S. to Series B+ in Europe, alongside a fund-of-funds approach.
They made 2 investments in the last 12 months. Average disclosed round size is $595.6M (across 11 rounds with reported amounts).
Portfolio
11
Fund Size
—
Top Stage
Series D
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
11 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series G | $575M | Mar 2026 | |
| LL-Nutra | Series D | $36.5M | Jan 2026 |
| Growth | $800M | Jul 2022 | |
| WWefox | Series D | $400M | Jul 2022 |
| Series E | $768M | Mar 2022 | |
| Series E | $300M | Sep 2021 | |
| Series D | $555M | Jun 2021 | |
| Series D | $125M | May 2021 | |
| Growth | $720M | Jan 2021 | |
| Growth | $2.3B | Mar 2020 | |
| Series A | $22M | — |
Top Co-Investors
Sequoia Capital3 shared
Andreessen Horowitz3 shared
Silver Lake3 shared
Tiger Global Management2 shared
DST Global2 shared
Dragoneer Investment Group2 shared
01 Advisors2 shared
Franklin Templeton2 shared
Growth Fund (ADG)1 shared
Alpha Wave Global1 shared
Magna1 shared
AutoNation1 shared
Alphabet1 shared
Wellington Management1 shared
Coatue Management1 shared
GIC1 shared
Siemens AG1 shared
Bestseller1 shared
Commonwealth Bank of Australia1 shared
Last updated: 10 April 2026